Florsheim, Germany

  • MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

    In this study the treatment group will include all patients receiving MILD, and the control group will include all patients receiving IPD for the treatment of LSS during the enrollment period. Reoperation and harms data will be studied for the MILD and IPD procedures for a 24-month follow-up period after the index procedure using Medicare claims data. This study is exempt from IRB oversight (Department of Health and Human Services regulations 45 CFR 46) and does not require prior enrollment nor patient consent. The inclusion of the study's NCT number on MILD Medicare claims is required and results in enrollment.

    Phase

    N/A

    Span

    512 weeks

    Sponsor

    Vertos Medical, Inc.

    Kenilworth, New Jersey

    Recruiting

  • A Safety and Efficacy Study of a Nutraceutical in Aging Males with Thinning Hair

    This multicenter, randomized, double-blind, placebo-controlled clinical trial is being conducted to assess the safety and efficacy of a dietary supplement with standardized botanicals compared to a placebo when used over the course of 9 months by men with self-perceived hair thinning.

    Phase

    N/A

    Span

    53 weeks

    Sponsor

    Nutraceutical Wellness Inc.

    Elizabeth, New Jersey

    Recruiting

    Healthy Volunteers

1-2 of 2